Immediate Evaluation for Clostridioides difficile Infection
Test this patient immediately for Clostridioides difficile infection (CDI) with stool toxin assay, as bowel urgency following antibiotic-induced colitis represents a potential CDI recurrence that requires microbiological confirmation before treatment. 1
Clinical Reasoning
This patient's presentation is highly concerning for CDI recurrence. Both Augmentin (amoxicillin-clavulanate) and metronidazole are well-established triggers for CDI 2, and the FDA label explicitly warns that "pseudomembranous colitis has been reported with nearly all antibacterial agents, including amoxicillin/clavulanate potassium" 2. The patient received the very antibiotics that commonly precipitate this condition.
Key Diagnostic Criteria
According to ESCMID guidelines, CDI recurrence is defined by:
- Stool frequency increases for two consecutive days AND stools become looser OR new signs of severe colitis develop, AND
- Microbiological evidence of toxin-producing C. difficile in stools without evidence of another cause 1
Critical point: You cannot diagnose CDI recurrence without microbiological confirmation. The symptom alone is insufficient.
Immediate Evaluation Steps
1. Stool Testing (Priority #1)
- Send stool for C. difficile toxin assay immediately
- Do NOT wait for results to worsen before testing
- Rule out other pathogens if clinically indicated
2. Assess Disease Severity
Determine if this represents non-severe vs. severe CDI by evaluating:
Signs of severe colitis include: 1
- Fever >38.5°C
- Hemodynamic instability
- Abdominal tenderness, rebound, or guarding
- Leukocytosis >15 × 10⁹/L
- Creatinine rise >50% above baseline
- Elevated serum lactate
3. Medication Review
- Immediately discontinue Augmentin if still being taken 1
- Continue to hold metronidazole pending test results
- Avoid antiperistaltic agents and opiates (B-II recommendation) 1
Treatment Algorithm Based on Test Results
If CDI Testing is POSITIVE:
For Non-Severe Disease (likely scenario given "urgency" as sole symptom):
- Metronidazole 500 mg PO three times daily for 10 days (A-I evidence) 1
- This represents treatment for a first recurrence
For Severe Disease (if severity criteria present):
- Vancomycin 125 mg PO four times daily for 10 days (A-I evidence) 1
Important caveat: If this patient develops a second recurrence after this treatment, escalate to vancomycin with taper/pulse strategy 1
If CDI Testing is NEGATIVE:
Consider alternative diagnoses:
- Post-infectious irritable bowel syndrome - Common after infectious colitis, can persist for months
- Antibiotic-associated diarrhea without CDI - May resolve with probiotic support and time
- Drug-induced ischemic colitis from Augmentin - Rare but documented 3, 4. Consider if urgency accompanied by cramping pain or hematochezia
- Underlying inflammatory bowel disease - Bowel urgency is a key symptom in IBD 5, 6, 7
Common Pitfalls to Avoid
- Do not empirically treat without testing - Microbiological confirmation is mandatory per guidelines 1
- Do not use antidiarrheals - These are contraindicated in CDI (B-II) 1
- Do not assume symptom resolution equals cure - CDI has high recurrence rates; spores persist despite vegetative bacterial clearance 1
- Do not overlook severity markers - Bowel urgency alone may mask evolving severe disease 1
Monitoring Strategy
- Observe closely for clinical deterioration over next 48-72 hours
- If symptoms worsen (increased stool frequency, fever, abdominal pain), reassess for severe CDI
- Treatment response should occur within 3 days for metronidazole 1
- Normal stool patterns may take weeks to return even after successful treatment 1
The bottom line: This is CDI recurrence until proven otherwise. Test immediately, assess severity, and treat according to confirmed diagnosis and disease severity using the algorithm above.